2020
DOI: 10.1016/j.foodres.2020.108989
|View full text |Cite
|
Sign up to set email alerts
|

Identification and characterisation of peptides from a boarfish (Capros aper) protein hydrolysate displaying in vitro dipeptidyl peptidase-IV (DPP-IV) inhibitory and insulinotropic activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
59
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

3
3

Authors

Journals

citations
Cited by 62 publications
(62 citation statements)
references
References 40 publications
3
59
0
Order By: Relevance
“…Thus, Harnedy-Rothwell et al identified IPVDM as the third-most potent food-derived DPP-4 inhibitor discovered to date, with an IC 50 of 21.7 µm. [85] Alongside this strong evidence for DPP-4 inhibitory action, several studies have also shown FPH to have strong insulin, GLP-1, and CCK release actions. [31][32][33]39,40,85,86] The in vivo efficacy of FPH has also been reasonably well established.…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…Thus, Harnedy-Rothwell et al identified IPVDM as the third-most potent food-derived DPP-4 inhibitor discovered to date, with an IC 50 of 21.7 µm. [85] Alongside this strong evidence for DPP-4 inhibitory action, several studies have also shown FPH to have strong insulin, GLP-1, and CCK release actions. [31][32][33]39,40,85,86] The in vivo efficacy of FPH has also been reasonably well established.…”
Section: Discussionmentioning
confidence: 94%
“…[85] Alongside this strong evidence for DPP-4 inhibitory action, several studies have also shown FPH to have strong insulin, GLP-1, and CCK release actions. [31][32][33]39,40,85,86] The in vivo efficacy of FPH has also been reasonably well established. Acutely, all studies investigating an anti-hyperglycemic effect of FPH has found a reduction in blood glucose with doses as low as 50 mg kg −1 bodyweight, [33] and several exhibiting an increase in plasma insulin [33,34] or GLP-1 [34] ; however, Iba et al [34] used extremely high doses of 1.5 g kg −1 and 3 g kg −1 bodyweight which would be impossible to translate to a human trial.…”
Section: Discussionmentioning
confidence: 94%
“…In terms of large-scale production, some authors have produced protein hydrolysates at a pilot or semi-pilot plant scale. In this context, different hydrolysates have been produced from such sources as fish discards [58] for their valorization, and trials have confirmed the results of production obtained at lab scale, or from boarfish [59], which show strong DPP-IV inhibitory activities.…”
Section: Enzymatic Hydrolysis Reactionmentioning
confidence: 85%
“…The literature reporting fish peptides with antidiabetic activity has been recently stated [59,[81][82][83]. In this context, the use of fishing discards as protein sources for value-added products is important [55,59,83,84]. The scientific community considers enzymatic hydrolysis as a helpful option for revaluing these low-quality products and increasing their potential, as they have no side effects on the patient's health.…”
Section: Protein Sourcementioning
confidence: 99%
See 1 more Smart Citation